Net Savings Link, Inc. Share Price

Equities

NSAV

US64112L2034

Blockchain & Cryptocurrency

Market Closed - OTC Markets 20:59:55 12/07/2024 BST 5-day change 1st Jan Change
0.0071 USD 0.00% Intraday chart for Net Savings Link, Inc. +9.23% +317.65%
Sales 2013 0.02 1.32 Sales 2014 - Capitalization 317K 24.43M
Net income 2013 - 0 Net income 2014 -1M -77.01M EV / Sales 2013 12,106,701 x
Net Debt 2013 113K 8.69M Net Debt 2014 149K 11.5M EV / Sales 2014 -
P/E ratio 2013
-0.1 x
P/E ratio 2014
-
Employees 1
Yield 2013 *
-
Yield 2014
-
Free-Float 100%
More Fundamentals * Assessed data
Dynamic Chart
1 week+9.23%
Current month-13.41%
1 month+42.00%
3 months+373.33%
6 months+373.33%
Current year+317.65%
More quotes
1 week
0.01
Extreme 0.0052
0.01
1 month
0.01
Extreme 0.005
0.01
Current year
0.00
Extreme 0.0012
0.02
1 year
0.00
Extreme 0.001
0.02
3 years
0.00
Extreme 0.001
0.15
5 years
0.00
Extreme 0
0.15
10 years
0.00
Extreme 0
0.25
More quotes
Managers TitleAgeSince
President 62 22/01/16
Members of the board TitleAgeSince
President 62 22/01/16
Director/Board Member 69 -
More insiders
Date Price Change Volume
12/07/24 0.0071 0.00% 6,899,284
11/07/24 0.0071 +1.43% 4,809,281
10/07/24 0.007 +9.37% 14,854,430
09/07/24 0.0064 +5.35% 15,961,462
08/07/24 0.006075 -6.54% 10,359,492

Delayed Quote OTC Markets, July 12, 2024 at 08:59 pm

More quotes
Net Savings Link, Inc. is a cryptocurrency, blockchain and digital asset technology company. The Company's primarily focused on making acquisitions and deals in the cryptocurrency sector. It plans to provide a wide range of services such as software solutions, e-commerce, advisory services, financial services and information technology. The Company owns the NSAV Premium OTC Cryptocurrency Trading Desk https://nsavholdinginc.com/otc-desk/. The Company owns the NSAV Decentralized Cryptocurrency Exchange, NSAVDEX 1 https://nsavdex.org/#/home running on Okex Chain. It owns the NSAV Decentralized Cryptocurrency Exchange, NSAVDEX 2 https://nsavdex.io/ running on Binance Smart Chain. The Company, through its Shanghai based subsidiary, Shanghai Hua Si Tai Medical Consultation Company Limited, provides clinical research to industry leaders such as Eli Lilly and the Medtronic Foundation. The Company's primary markets for its products and services are the United States, Europe and China.
More about the company